期刊文献+

心钠素基因多态性与原发性高血压患者左心室肥厚的关系 被引量:1

Association between gene polymorphism of atrial natriuretic peptide and left ventricular hypertrophy in patients with primary hypertension
下载PDF
导出
摘要 目的探讨人类心钠素(ANP)基因多态性与原发性高血压患者左心室肥厚的关系。方法选择原发性高血压患者106例,根据心脏超声检查结果分为单纯高血压组(对照组)75例和高血压合并左心室肥厚组(观察组)31例,采用PCR技术检测人类ANP基因C664G、G1837A和T2238C位点的多态性,比较两组基因型及等位基因分布差异。结果观察组患者人类ANP基因C664G位点GG基因型频率为54.8%,高于对照组的33.3%(P<0.05)。两组患者人类ANP基因G1837A位点和T2238C位点基因型和各等位基因频率差异无统计学意义。结论人类ANP基因C664G位点的基因变异可能与原发性高血压患者左心室肥厚有关。 Objective To investigate the association between the gene polymorphism of human atrial natriuretic peptide (hANP) and left ventricular hypertrophy in a southern Chinese Han population with primary hypertension.Methods A total of 106 cases of patients with primary hypertension were divided into hypertension group (75cases,control group) and left ventricular hypertrophy group (31case,observation group) according to cardiac echocardiography.The gene polymorphisms of hANP C664G,G1837A and T2238C were measured by PCR,and differences of genotypes and allele frequencies between the two groups were investigated.Resiults The frequency of C664G GG genotype in the observation group was 54.8%,which was higher than that of the control group (33.3%) (P 〈 0.05).No significant differences were found in G1837A and T2238C genotypes between the two groups (P 〉 0.05).Conclusion The polymorphism of hANP C664G gene is related with the left ventricular hypertrophy in patients with primary hypertension.
出处 《山东医药》 CAS 2013年第46期15-17,共3页 Shandong Medical Journal
基金 深圳市科技计划项目(200902018)
关键词 原发性高血压 左心室肥厚 心钠素 基因多态性 primary hypertension left ventricular hypertrophy atrial natriuretic factor gene polymorphism
  • 相关文献

参考文献16

  • 1Gradman AH,Alfayoumi F. From left ventricular hypertrophy to congestive heart failure:management of hypertensive heart disease[J].{H}Progress in Cardiovascular Diseases,2006,(05):326-341.
  • 2Artham SM,Lavie C J,Milani RV. Clinical impact of left ventricular hypertrophy and implications for regression[J].{H}Progress in Cardiovascular Diseases,2009,(02):153-167.
  • 3Levin ER,Gardner DG,Samson WK. Natriuretic peptides[J].{H}New England Journal of Medicine,1998,(05):321-328.
  • 4Martinez-Rumayor A,Richards AM,Burnett JC,Januzzi JL Jr. Biology of natriuretic peptides[J].{H}American Journal of Cardiology,2008,(3A):3-8.
  • 5de Bold AJ. Thirty years of research on atrial natriuretic factor:historical background and emerging concept[J].{H}Canadian Journal of Physiology and Pharmacology,2011,(08):527-531.
  • 6Cuspidi C,Sala C,Negri F. Prevalence of left-ventricular hypertrophy in hypertension:an updated review of echocardiographic studie[J].{H}Journal OF HUMAN HYPERTENSION,2012,(06):343-349.
  • 7Cacciapuoti F. Molecular mechanisms of left ventricular hypertrophy (LVH) in systemic hypertension (SH)-possible therapeutic perspective[J].J Am Soc Hypertens,2011,(06):449-455.
  • 8Barry L. Natriuretic peptides and cardiac hypertrophy[J].{H}Journal of the America College of Cardiology,2006,(03):506-507.
  • 9Dries DL. Natriuretic peptides and the genomics of left-ventricular hypertrophy[J].Heart Fail Clin,2010,(01):55-64.
  • 10Woodard GE,Rosado JA. Recent advances in natriuretic peptide research[J].{H}Jourmal Cell Mol Med,2007,(06):1263-1271.

同被引文献14

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部